St. Barnabas is a clinical research site located in Livingston, New Jersey, United States 07039.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
St. Barnabas has participated in 3 clinical trials.
Therapeutic areas: Kidney Transplantation, Primary Focal Segmental Glomerulosclerosis (FSGS), Coronavirus Disease 2019.
Sponsors: Astellas Pharma Global Development, Inc., CytoDyn, Inc., Prolong Pharmaceuticals.
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
St. Barnabas has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
St. Barnabas has 3 clinical trials on record. Their work covers Kidney Transplantation, Primary Focal Segmental Glomerulosclerosis (FSGS), Coronavirus Disease 2019.
St. Barnabas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.